Cardiovascular risk assessment for osteoporosis patients considering Romosozumab

F Macrae; E M Clark; K Walsh; S J Bailey; M Roy; S Hardcastle; C Cockill; J H Tobias; B G Faber

doi:10.1016/j.bone.2024.117305

Cardiovascular risk assessment for osteoporosis patients considering Romosozumab

F Macrae^*, E M Clark, K Walsh, S J Bailey, M Roy, S Hardcastle, C Cockill, J H Tobias, B G Faber

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

2 Citations (Scopus)

28 Downloads (Pure)

Abstract

Cardiovascular risk scoring tools are suitable for but not interchangeable within the osteoporosis clinic.

Original language	English
Article number	117305
Number of pages	2
Journal	Bone
Volume	190
Early online date	23 Oct 2024
DOIs	https://doi.org/10.1016/j.bone.2024.117305
Publication status	Published - 1 Jan 2025

Bibliographical note

Access to Document

10.1016/j.bone.2024.117305

Full-text PDF (accepted manuscript)
This is the accepted author manuscript (AAM) of the article which has been made Open Access under the University of Bristol's Scholarly Works Policy. The final published version (Version of Record) can be found on the publisher's website. The copyright of any third-party content, such as images, remains with the copyright holder.
Accepted author manuscript, 197 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{2d74c02fcd30451099c979f63b92e8ad,

title = "Cardiovascular risk assessment for osteoporosis patients considering Romosozumab",

abstract = "Cardiovascular risk scoring tools are suitable for but not interchangeable within the osteoporosis clinic.",

author = "F Macrae and Clark, {E M} and K Walsh and Bailey, {S J} and M Roy and S Hardcastle and C Cockill and Tobias, {J H} and Faber, {B G}",

note = "Copyright {\textcopyright} 2024. Published by Elsevier Inc.",

year = "2025",

month = jan,

day = "1",

doi = "10.1016/j.bone.2024.117305",

language = "English",

volume = "190",

journal = "Bone",

issn = "8756-3282",

publisher = "Pergamon Press",

}

TY - JOUR

T1 - Cardiovascular risk assessment for osteoporosis patients considering Romosozumab

AU - Macrae, F

AU - Clark, E M

AU - Walsh, K

AU - Bailey, S J

AU - Roy, M

AU - Hardcastle, S

AU - Cockill, C

AU - Tobias, J H

AU - Faber, B G

PY - 2025/1/1

Y1 - 2025/1/1

N2 - Cardiovascular risk scoring tools are suitable for but not interchangeable within the osteoporosis clinic.

AB - Cardiovascular risk scoring tools are suitable for but not interchangeable within the osteoporosis clinic.

U2 - 10.1016/j.bone.2024.117305

DO - 10.1016/j.bone.2024.117305

M3 - Article (Academic Journal)

C2 - 39454743

SN - 8756-3282

VL - 190

JO - Bone

JF - Bone

M1 - 117305

ER -

Cardiovascular risk assessment for osteoporosis patients considering Romosozumab

Abstract

Bibliographical note

Access to Document

Handle.net

Fingerprint

Cite this